ATRAptarGroup, Inc.
Is it safe?
Strong, no red flags: a safe balance sheet and steady price behavior.
Financially healthy, low distress risk Altman Z-score, a bankruptcy-risk model from five balance-sheet ratios.
Insiders were net sellers (-$3.6M, 90 days to Oct 8, 2026), selling is often routine.
Investment-grade balance sheet. A rule of thumb on leverage, not a credit rating.
Relatively steady, low volatility. Worst drawdown -40% · now 17% below its 52-week high.
Unless marked, from SEC EDGAR, as of Dec 31, 2025.
Against the whole market›
Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.
Where this answer is blind. Altman sits structurally low for utilities and pipelines; Beneish runs high for fast growers, since sales growth alone lifts it; banks and REITs are excluded.
Can ATR take a bad year?
The deepest fall in ATR's price history on file is −40%; it is 17% below its high today.
Net debt · as at Q2 2026 · debt less the cash on hand
- Altman Z-score
- 3.79
Altman Z-score · safe zone, above 3
- Interest cover
- 7.52×
Interest cover · operating profit covers the interest bill several times over
- Annualised volatility
- 24%
Annualised volatility · about as steady as the market itself
Details›
- Total debtQ2 2026
- $1.37B
- Cash and short-term investments
- $197M
- Net debt
- $1.17B
- Operating profit, trailing twelve months
- $477M
- Debt / equity
- 0.52×
- Annualised volatilitytwo years of daily moves
- 24%
- Worst drawdown on file
- −40%
- Below its 52-week high
- 17%
Balance sheet from SEC filings; drawdown and volatility from end-of-day closes; Altman Z from the filed statements.
Medical Instruments & Supplies
Ranks #1 of 21 by RyuScore